Women's choices between injectable and daily HIV prevention in Malawi

Better Info on Women's PrEP Choices and Outcomes in Malawi

NIH-funded research Johns Hopkins University · NIH-11182713

This project will see how women in Malawi choose, switch, and stay on long-acting injectable versus daily oral HIV prevention (PrEP).

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11182713 on NIH RePORTER

What this research studies

If you join, researchers will follow women offered both injectable and oral PrEP through a real-world rollout in Malawi to learn what people pick and why. They will use clinic records from the PathToScale program and talk with women over time to track starts, switches, and stops. The team will look at which options people continue with and the reasons behind decisions, especially for women who stop using PrEP. Findings will be used to help clinics offer PrEP in ways that fit women's needs and lives.

Who could benefit from this research

Good fit: Women in Malawi who are offered or using oral or injectable PrEP through the participating rollout programs would be the ideal candidates.

Not a fit: People who are not women, not in Malawi, or not enrolled in the participating PrEP rollout clinics would not be able to join or directly benefit from this work.

Why it matters

Potential benefit: Could help health programs offer PrEP options that more women prefer and stay on, reducing new HIV infections.

How similar studies have performed: Clinical trials have shown long-acting injectable PrEP can prevent HIV well, but large real-world studies tracking women's choices and continuation during rollout are still limited.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency SyndromeAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency SyndromeAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.